Health Canada Updates
The latest guidances, approvals, and safety alerts from Health Canada, curated by automated regulatory intelligence.
Reviews and may reshape Canada’s federal approach to obtaining pandemic science advice and coordinating pandemic research, with implications for how evidence…
National Pharmacare Committee of Experts—Health Canada advisory body—sets up expert governance intended to inform or support the development of Canada’s…
Establishes and describes Health Canada’s Ministerial Advisory Council on Mental Health as an advisory body to support ministerial decision-making in the…
Constitutes or highlights Health Canada’s Expert Task Force on Substance Use within the broader advisory body framework, indicating ongoing policy/scientific…
Expert Panel materials on MAID and mental illness indicate Health Canada is examining how psychiatric/mental health conditions intersect with eligibility…
Expert Advisory Group on Safer Supply establishes an advisory mechanism within Health Canada to support approaches aimed at improving the safety of the…
Advises on priorities and evidence-gathering activities related to pain, informing Health Canada’s engagement and potential downstream updates to policies or…
Establishes an advisory committee structure within Health Canada for considering the appropriate use of health products and/or evidence-based recommendations.
Advises on how to implement National Pharmacare in Canada through guidance from an advisory council focused on policy rollout considerations rather than…
Constitutes Health Canada’s Scientific Advisory Board on Vaping Products, indicating a structured expert advisory mechanism to inform vaping product-related…
Establishes and convenes a Health Canada youth-focused advisory committee framework on substance use to inform ongoing policy and program considerations.
Establishes and supports an Implementation Advisory Group (IAG) to coordinate Health Canada’s implementation of the National Strategy for Drugs for Rare…
Scientific Advisory Committee on Mental Health Disorders event notice from Health Canada, indicating planned expert scientific discussion that may inform…
Scientific Advisory Committee meeting materials on medical devices used in the cardiovascular system provide a structured forum for Health Canada to solicit…
Science Advisory Committee on Pest Control Products meetings are intended to inform Health Canada’s regulatory decision-making for pest control products by…
Science Advisory Committee convenes to advise on health products containing cannabis, indicating ongoing Health Canada oversight and evidence-building to…
Guidance on nitrosamine impurities in medications is updated, potentially tightening expectations for manufacturers to evaluate, control, and communicate…
Implements ICH M13B to support regulatory decisions on bioequivalence for immediate-release solid oral dosage forms, including use of additional-strength…
Phased implementation of ICH M11 (CeSHarP) is expected to move Canadian sponsors toward standardized, electronic, structured harmonised clinical protocol…
Estradiol transdermal patches for menopause hormone therapy may be affected by a Canada-wide short supply situation, prompting regulator notice-level oversight…